In recent years, a large number of diseases, including autoimmune afflictions, have been treated with the help of powerful therapeutic antibodies. The most common way to administer this treatment is the use of injections. While the method will deliver the antibodies directly into the bloodstream, systemic side effects and other complications could appear due to its invasive nature. A new method of treatment implies edible antibodies.
Some researchers have already tried to explore the possibilities of oral ingestion, but the digestive system can destroy the antibodies. A team of scientist has managed to create a new type of treatment which should allow the antibodies to withstand the harsh conditions found in the stomach. The new kind of therapy has the potential to cure gut-related conditions.
These edible antibodies are manufactured by using soybean seeds or yeast cells and food processing methods which are readily available in most parts of the world. Manufacturing them is as easy as producing other foods. By using the existent technology, the team was able to remove the purification processes, an achievement which can decrease the costs without compromising the efficiency of the antibodies.
The new edible antibodies proved efficient against Escherichia Coli
The efficiency of the new treatment was tested with the help of small piglets. It is well-known that the young creatures are susceptible to infections which cause diarrhea. In most cases, the culprit is a variant of Escherichia Coli, which causes disease among pig populations from all over the world. A pilot study has shown that piglets which received food enhanced with the new antibodies were less likely to contract the bacteria.
The edible antibodies come in the form of a powder which can be administered to the humans and animals alike. The powder can be added to all types of food. More tests are required to see if the new solution will be efficient in the long run, but the first results are quite promising. The potential is there, and the treatment could be beneficial in the case of vulnerable populations.
Jasmine holds a Master’s in Journalism from Ryerson University in Toronto and writes professionally in a broad variety of genres. She has worked as a senior manager in public relations and communications for major telecommunication companies, and is the former Deputy Director for Media Relations with the Modern Coalition. Jasmine writes primarily in our LGBTTQQIAAP and Science section.